Neurology. 2006 Oct 10;67(7):1262-4.

Creatine supplementation in Parkinson disease: a placebo-controlled randomized pilot trial.

Bender A, Koch W, Elstner M, Schombacher Y, Bender J, Moeschl M, Gekeler F, Müller-Myhsok B, Gasser T, Tatsch K, Klopstock T.

Source

Department of Neurology, Klinikum Grosshadern, Klinikum Grosshadern, University of Munich, Germany.

Abstract

Mitochondrial dysfunction plays a major role in the pathogenesis of Parkinson disease (PD). Creatine (Cr) is an ergogenic compound that exerts neuroprotective effects in animal models of PD. We conducted a 2-year placebo-controlled randomized clinical trial on the effect of Cr in 60 patients with PD. Cr improved patient mood and led to a smaller dose increase of dopaminergic therapy but had no effect on overall Unified Parkinson's Disease Rating Scale scores or dopamine transporter SPECT.

PMID:: 17030762; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

Creatine

LinkOut - more resources

Full Text Sources

Medical

Molecular Biology Databases

CREATINE - HSDB

Supplemental Content

Save items

Related citations in PubMed

Depression in Parkinson's disease: a double-blind, randomized, placebo-controlled pilot study of omega-3 fatty-acid supplementation. [J Affect Disord. 2008]
Depression in Parkinson's disease: a double-blind, randomized, placebo-controlled pilot study of omega-3 fatty-acid supplementation.
da Silva TM, Munhoz RP, Alvarez C, Naliwaiko K, Kiss A, Andreatini R, Ferraz AC. J Affect Disord. 2008 Dec; 111(2-3):351-9. Epub 2008 May 15.
Long-term creatine supplementation is safe in aged patients with Parkinson disease. [Nutr Res. 2008]
Long-term creatine supplementation is safe in aged patients with Parkinson disease.
Bender A, Samtleben W, Elstner M, Klopstock T. Nutr Res. 2008 Mar; 28(3):172-8.
The effect of pramipexole on mood and motivational symptoms in Parkinson's disease: a meta-analysis of placebo-controlled studies. [Clin Ther. 2009]
The effect of pramipexole on mood and motivational symptoms in Parkinson's disease: a meta-analysis of placebo-controlled studies.
Leentjens AF, Koester J, Fruh B, Shephard DT, Barone P, Houben JJ. Clin Ther. 2009 Jan; 31(1):89-98.
Review [Coenzyme Q10 in Parkinson's disease. Symptomatic or neuroprotective effects?]. [Nervenarzt. 2007]
Review [Coenzyme Q10 in Parkinson's disease. Symptomatic or neuroprotective effects?].
Storch A. Nervenarzt. 2007 Dec; 78(12):1378-82.
Review Comprehensive review of rasagiline, a second-generation monoamine oxidase inhibitor, for the treatment of Parkinson's disease. [Clin Ther. 2007]
Review Comprehensive review of rasagiline, a second-generation monoamine oxidase inhibitor, for the treatment of Parkinson's disease.
Chen JJ, Swope DM, Dashtipour K. Clin Ther. 2007 Sep; 29(9):1825-49.

See reviews... See all...

Cited by 9 PubMed Central articles

Stuck at the bench: Potential natural neuroprotective compounds for concussion. [Surg Neurol Int. 2011]
Stuck at the bench: Potential natural neuroprotective compounds for concussion.
Petraglia AL, Winkler EA, Bailes JE. Surg Neurol Int. 2011; 2:146. Epub 2011 Oct 12.
Review Role and treatment of mitochondrial DNA-related mitochondrial dysfunction in sporadic neurodegenerative diseases. [Curr Pharm Des. 2011]
Review Role and treatment of mitochondrial DNA-related mitochondrial dysfunction in sporadic neurodegenerative diseases.
Swerdlow RH. Curr Pharm Des. 2011; 17(31):3356-73.
Mitochondrial dysfunction in Parkinson's disease: pathogenesis and neuroprotection. [Parkinsons Dis. 2010]
Mitochondrial dysfunction in Parkinson's disease: pathogenesis and neuroprotection.
Mounsey RB, Teismann P. Parkinsons Dis. 2010 Dec 26; 2011:617472. Epub 2010 Dec 26.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Creatine supplementation in Parkinson disease: a placebo-controlled randomized p...
Creatine supplementation in Parkinson disease: a placebo-controlled randomized pilot trial.
Neurology. 2006 Oct 10 ;67(7):1262-4.

PubMed
Safinamide: from molecular targets to a new anti-Parkinson drug.
Safinamide: from molecular targets to a new anti-Parkinson drug.
Neurology. 2006 Oct 10 ;67(7 Suppl 2):S18-23.

PubMed
Intravitreal triamcinolone in diabetic macular edema.
Intravitreal triamcinolone in diabetic macular edema.
Arch Ophthalmol. 2006 Oct ;124(10):1506-7; author reply 1507.

PubMed
Association of connective tissue growth factor with fibrosis in vitreoretinal di...
Association of connective tissue growth factor with fibrosis in vitreoretinal disorders in the human eye.
Arch Ophthalmol. 2006 Oct ;124(10):1457-62.

PubMed
The progression of cognition, psychiatric symptoms, and functional abilities in ...
The progression of cognition, psychiatric symptoms, and functional abilities in dementia with Lewy bodies and Alzheimer disease.
Arch Neurol. 2006 Oct ;63(10):1450-6.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: